Steris (STE) Depreciation & Amortization (CF) (2018 - 2026)
Steris (STE) posted Depreciation & Amortization (CF) of $123.8 million for Q2 2026, little changed on a QoQ basis from $123.4 million in Q1 2026, and up 3.69% year-over-year from $119.4 million in Q2 2025.
Analysis
Steris (STE) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Steris has reported Depreciation & Amortization (CF) for 9 years, with the latest figure at $123.8 million in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 3.69% year-over-year to $123.8 million in Q2 2026; TTM through Jun 2026 was $490.9 million, a 1.66% increase from a year earlier, with the FY2026 full-year figure at $486.5 million, up 2.16% from the prior year.
- Depreciation & Amortization (CF) was $123.8 million for Q2 2026 at Steris, roughly flat from $123.4 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $233.8 million in Q1 2022, with the low at $112.7 million in Q2 2024.
- Average Depreciation & Amortization (CF) over 5 years is $135.5 million, with a median of $129.9 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) soared 296.03% in 2022, then tumbled 39.19% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $138.0 million in 2022, then advanced by 1.94% to $140.6 million in 2023, then fell by 10.47% to $125.9 million in 2024, then fell by 3.1% to $122.0 million in 2025, then increased by 1.48% to $123.8 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $123.8 million (Q2 2026), $123.4 million (Q1 2026), and $122.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 270.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 123.80 Mn |
| Mar 31, 2026 | 123.40 Mn |
| Dec 31, 2025 | 122.00 Mn |
| Sep 30, 2025 | 121.70 Mn |
| Jun 30, 2025 | 119.40 Mn |
| Mar 31, 2025 | 122.30 Mn |
| Dec 31, 2024 | 125.90 Mn |
| Sep 30, 2024 | 115.30 Mn |
| Jun 30, 2024 | 112.70 Mn |
| Mar 31, 2024 | 134.39 Mn |
| Dec 31, 2023 | 140.63 Mn |
| Sep 30, 2023 | 152.25 Mn |
| Jun 30, 2023 | 137.93 Mn |
| Mar 31, 2023 | 142.20 Mn |
| Dec 31, 2022 | 137.95 Mn |
| Sep 30, 2022 | 133.88 Mn |
| Jun 30, 2022 | 138.86 Mn |
| Mar 31, 2022 | 233.83 Mn |
| Dec 31, 2021 | 117.61 Mn |
| Sep 30, 2021 | 118.04 Mn |